Health and Fitness Health and Fitness
Mon, June 27, 2011
[ 01:00 AM ] - Market Wire
QNEXA® Data Featured at the American Diabetes Association's 71st Scientific Sessions
Sat, June 25, 2011
[ 05:00 AM ] - Market Wire
Investigational Study Reported ONGLYZAa" (saxagli .. icantly Improved Blood Sugar Levels in Adults wit
Fri, June 24, 2011
[ 06:00 PM ] - Market Wire
Accuray Hosts Korean Embassy's Minister for Econo .. nt to Support the U.S.-Korea Free Trade Agreement
[ 06:00 PM ] - Market Wire
Studies Show Effect of BYDUREONa" on A1C and Weight for Up to Three Years
[ 06:00 PM ] - Market Wire
Phase 2 Study Results Presented at ADA 2011
[ 06:00 PM ] - Market Wire
Analysis Compares Cost-Effectiveness of Premixed .. g Insulin Analogs in the Long-Term Treatment of T
[ 06:00 PM ] - Market Wire
Analysis Shows BYDUREONa" Was Not Associated with .. ngation in Patients with Type 2 Diabetes: Results
[ 04:40 PM ] - Market Wire
Halozyme's Ultrafast Insulin Demonstrates Reduced .. rption for Type 1 Diabetes Patients Using Insulin
[ 04:40 PM ] - Market Wire
Endo Pharmaceuticals Issues Voluntary, Nationwide .. t® (Oxycodone/Acetaminophen, USP) Tablets, 10 Mg
[ 04:40 PM ] - Market Wire
Positive Results for Investigational Compound Lyx .. ed at American Diabetes Association's 71st Annual
[ 04:40 PM ] - Market Wire
Sanofi Announces Positive Results from the "All t .. Lantus® and Apidra® Regimens Versus Premixed Re
[ 04:40 PM ] - Market Wire
Qualitest Pharmaceuticals Issues Voluntary, Natio .. Four Lots of Butalbital, Acetaminophen, and Caffe
[ 04:40 PM ] - Market Wire
Analysis Finds BYETTA® Associated with Lower Lik .. red with Other Diabetes Therapies: Results Presen
[ 02:00 PM ] - Market Wire
Allergan Receives FDA Approval for First-of-Its-K .. Assay for BOTOX® and BOTOX® Cosmetic (onabotul
[ 01:30 PM ] - Market Wire
Columbia Laboratories Added to Russell 3000 Index
[ 09:09 AM ] - Market Wire
Linagliptin recommended for approval in the treatment of type 2 diabetes in Europe
[ 08:48 AM ] - Market Wire
LUX BIOSCIENCES TO APPEAL EMA DECISION ON LUVENIQ&;#8482;
[ 06:24 AM ] - Market Wire
NovaDel Pharma Inc. to Present at 2011 BIO International Convention
[ 05:45 AM ] - Market Wire
Baxter Receives Positive Opinion for IVIG Therapy .. rope for Treatment of Multifocal Motor Neuropathy
[ 05:00 AM ] - Market Wire
FDA Complete Response Letter Received for REMOXY
[ 04:15 AM ] - Market Wire
RXi Pharmaceuticals to Present at BIO International Convention
[ 04:00 AM ] - Market Wire
Acorda Therapeutics Wins Two 2011 Stevie Awards at the 9th Annual American Business Awards
[ 01:05 AM ] - Market Wire
ViroPharma Announces Positive CHMP Opinion for Bu .. zolam, Oromucosal Solution) in the European Union
[ 01:05 AM ] - Market Wire
FDA Advisory Committee Strongly Recommends Approv .. FIRAZYR® (icatibant) for the Treatment of Acute
[ 01:05 AM ] - Market Wire
China-Biotics, Inc. Receives NASDAQ Delisting Notification
Thu, June 23, 2011
[ 04:53 PM ] - Market Wire
Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
[ 03:42 PM ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces Investigation of SeraCare Life Sciences, Inc.
[ 03:00 PM ] - Market Wire
Mylan Launches First Generic Version of Entocort EC® Capsules
[ 02:30 PM ] - Market Wire
LABOPHARM ANNOUNCES REDUCTION OF ANGELINI LABOPHARM';S OLEPTRO&;#8482; SALES FORCE
[ 01:24 PM ] - Market Wire
Pfizer Declares A 20-Cent Third-Quarter 2011 Dividend

Pfizer Declares A 20-Cent Third-Quarter 2011 Dividend


Published on 2011-06-23 13:35:33 - Market Wire
  Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 20-cent third-quarter 2011 dividend on the companya™s common stock, payable September 6, 2011, to shareholders of record at the close of business on August 5, 2011.

The third-quarter 2011 cash dividend will be the 291st consecutive quarterly dividend paid by Pfizer.

Contributing Sources